Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.54 - $11.49 $58,435 - $121,196
-10,548 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$11.35 - $13.7 $62,425 - $75,350
-5,500 Reduced 34.27%
10,548 $123,000
Q4 2021

Feb 14, 2022

SELL
$11.95 - $13.34 $144,284 - $161,067
-12,074 Reduced 42.93%
16,048 $205,000
Q3 2021

Nov 15, 2021

SELL
$12.2 - $15.93 $346,065 - $451,870
-28,366 Reduced 50.22%
28,122 $384,000
Q2 2021

Aug 16, 2021

BUY
$11.7 - $16.11 $660,909 - $910,021
56,488 New
56,488 $910,000
Q1 2020

May 15, 2020

SELL
$5.39 - $18.33 $64,065 - $217,870
-11,886 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$11.26 - $13.8 $133,836 - $164,026
11,886 New
11,886 $154,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $58.2M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.